Found 3824 chains in Genus chains table. Displaying 1151 - 1200. Applied filters: Proteins

Search results query: proteasome subunit alpha type-2

Total Genus Sequence Length pdb Title
66 250 5l5zA Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib
67 233 5m2bM Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19
66 231 5l5rE Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133)
70 240 5l5zC Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib
57 195 5l5zJ Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib
59 226 5l5zH Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib
67 233 5l5vM 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
58 226 5l5pH Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
64 241 5l5xG Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914
65 241 5l5tG Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
68 233 5l5xM Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914
69 244 5l5yB Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib
68 242 5l5yD Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib
70 243 5l5xF Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914
61 222 5l5uL Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
63 211 5l5tK Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
58 226 5l5oH Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
59 196 5l5uN Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
66 250 5l5vA 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
69 243 5l5tF Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
58 204 5l5zI Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib
63 211 5l5iK Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9
58 204 5l61I Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14
70 244 5l61B Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14
70 244 5m2bB Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19
68 211 5l61K Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14
59 196 5l5vN 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
67 233 5l61M Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14
69 244 5l5vB 'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
69 243 5l5uF Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
57 226 5l5tH Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
57 195 5l60J Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
57 204 5m2bI Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19
65 250 5l60A Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
58 196 5l60N Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
68 242 5l5wD Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133)
60 195 5l68J Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14
41 419 5m32k Human 26s proteasome in complex with oprozomib
67 250 5m2bA Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19
69 244 5l69B Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
67 348 5m32f Human 26s proteasome in complex with oprozomib
64 366 5m32e Human 26s proteasome in complex with oprozomib
67 250 5l67A Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924
34 196 5m32J Human 26s proteasome in complex with oprozomib
47 234 5m32C Human 26s proteasome in complex with oprozomib
47 235 5m32Q Human 26s proteasome in complex with oprozomib
67 242 5l6cD Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
5 76 5m32o Human 26s proteasome in complex with oprozomib
68 233 5l6cM Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
58 222 5l65L Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib